Cart

YOUR CART IS EMPTY

Add research compounds to begin your order.

Exact TB-500 identity and direct-fragment evidenceSee approved evidence mapOngoing

TBRIDGE-CV (NCT07487363): TB-500 17–23 Fragment Registry Study

TB5-STUDY-P012

ClinicalTrials.gov. NCT07487363, TBRIDGE-CV. Registry record; no results at the evidence cutoff. https://clinicaltrials.gov/study/NCT07487363

Study design

Record details

Design: Exact TB-500 identity and direct-fragment evidence

Evidence record

Endpoints, findings, and limitations

Limitations

This study record is an evidence-index entry. Interpret the design, material, population or model, endpoints, findings, and limitations only within the linked approved source and compound evidence map; do not transfer outcomes across compounds, materials, cohorts, or models.

Reports and sources

Reference ledger

P012Exact TB-500 identity and direct-fragment evidence

ClinicalTrials.gov. NCT07487363, TBRIDGE-CV. Registry record; no results at the evidence cutoff. https://clinicaltrials.gov/study/NCT07487363

ClinicalTrials.gov. NCT07487363, TBRIDGE-CV. Registry record; no results at the evidence cutoff. https://clinicaltrials.gov/study/NCT07487363